Current sickle cell disease (SCD) trial eligibility criteria exclude most adults, with only 9.9% meeting inclusion thresholds ...

Historically characterized by excessive daytime sleepiness and cataplexy, narcolepsy is increasingly recognized as a ...

Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable ...

Phase 1 BALLI-01 trial results showed promising UCART22 activity in R/R B-cell ALL, with higher remission rates after a ...

First, the AASM guideline recommends a combination of CBT‑I and medication over medication alone for adults with chronic ...

Standardized order sets, clinical team training on toxicity grading and treatment algorithms, and immediate access to ...

This analysis compared health care resource utilization and costs for Medicaid patients with serious mental illness between ...

Prolonged follow-up showed superior PFS with mosun-pola versus R-GemOx in the overall SUNMO population (HR, 0.41) alongside ...

After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...

Alexander Spira, MD, PhD, medical oncologist at Virginia Cancer Specialists and chief scientific officer of NEXT Oncology, ...

Implementation barriers remain largely programmatic, requiring integrated HIV testing, adherence support, STI services, and ...

Patients with narcolepsy type 1 reported high disease burden, including chronic symptoms like hallucinations, sleep paralysis ...